Resectable carcinoma developing in the remnant pancreas 3 years after pylorus-preserving pancreaticoduodenectomy for invasive ductal carcinoma of the pancreas.

Resectable carcinoma developing in the remnant pancreas 3 years after pylorus-preserving pancreaticoduodenectomy for invasive ductal carcinoma of the pancreas. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Resectable carcinoma developing in the remnant pancreas 3 years after pylorus-preserving pancreaticoduodenectomy for invasive ductal carcinoma of the pancreas. Abstract Text:

Yoshitsugu Tajima,Tamotsu Kuroki,Tsuyoshi Ohno,Junichiro Furui,Noritsugu Tsuneoka,Tomohiko Adachi,Takehiro Mishima,Taiichiro Kosaka,Masashi Haraguchi,Takashi Kanematsu,

Resectable carcinoma developing in the remnant pancreas 3 years after pylorus-preserving pancreaticoduodenectomy for invasive ductal carcinoma of the pancreas. Publishing Authors By Initials

Y Tajima,T Kuroki,T Ohno,J Furui,N Tsuneoka,T Adachi,T Mishima,T Kosaka,M Haraguchi,T Kanematsu,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Resectable carcinoma developing in the remnant pancreas 3 years after pylorus-preserving pancreaticoduodenectomy for invasive ductal carcinoma of the pancreas. Journal Published:

PUBLICATION TYPE: Letter

Journal: Pancreas

VOLUME: 36

Page Numbers: 324-7

Journal Abbreviation: Pancreas

ISSN: 1536-4828

DAY: 25

MONTH: Apr

YEAR: 2008

Resectable carcinoma developing in the remnant pancreas 3 years after pylorus-preserving pancreaticoduodenectomy for invasive ductal carcinoma of the pancreas. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8608542

Resectable carcinoma developing in the remnant pancreas 3 years after pylorus-preserving pancreaticoduodenectomy for invasive ductal carcinoma of the pancreas. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Resectable carcinoma developing in the remnant pancreas 3 years after pylorus-preserving pancreaticoduodenectomy for invasive ductal carcinoma of the pancreas. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Resectable carcinoma developing in the remnant pancreas 3 years after pylorus-preserving pancreaticoduodenectomy for invasive ductal carcinoma of the pancreas.

AFFILIATION:

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Pancreas

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Resectable carcinoma developing in the remnant pancreas 3 years after pylorus-preserving pancreaticoduodenectomy for invasive ductal carcinoma of the pancreas Related Publications

• A jejunal wall-covering method following central pancreatectomy for prevention of a pancreatic fistula: a novel technique.
• Bladder wall grafting in rats using salt-modified and collagen-coated polycaprolactone scaffolds: preliminary report.
• Chemopreventive effects of a selective cyclooxygenase-2 inhibitor (etodolac) on chemically induced intraductal papillary carcinoma of the pancreas in hamsters.
• Coherent oscillations in ultrafast fluorescence of photoactive yellow protein.
• Compressive stenosis of the inferior vena cava due to localized ascites after living-donor liver transplantation.
• Congenital occurrence of solitary infantile myofibromatosis of the spleen.
• Cross-presentation of NY-ESO-1 cytotoxic T lymphocyte epitope fused to human heat shock cognate protein 70 by dendritic cells.
• De novo autoimmune hepatitis after living donor liver transplantation is unlikely to be related to immunoglobulin subtype 4-related immune disease.
• Evolution of living donor liver transplantation over 10 years: Experience of a single center.
• Experience of gastric cancer in a patient who had received a living-donor liver transplantation.
• Giant cystic meconium peritonitis associated with a cloacal anomaly: case report.
• Glycine reduces hepatic warm ischaemia-reperfusion injury by suppressing inflammatory reactions in rats.
• How should we evaluate CT during arterial portography in patients with cirrhosis?
• Human T-cell leukemia virus type I-associated myelopathy following living-donor liver transplantation.
• Inflammatory cytokines promote inducible nitric oxide synthase-mediated DNA damage in hamster gallbladder epithelial cells.
• Intentional conversion from tacrolimus to cyclosporine for HCV-positive patients on preemptive interferon therapy after living donor liver transplantation.
• Obturator hernia in an ageing society.
• Preliminary Study for Automated Recognition of Anatomical Structure from Torso CT images.
• Prognostic impact of marginal adipose tissue invasion in ductal carcinoma of the breast.
• Protective effects of a hibernation-inducer on hepatocyte injury induced by hypothermic preservation.
• Quality control of CT system for treatment planning using the polybinary calibration method.
• Resectable carcinoma developing in the remnant pancreas 3 years after pylorus-preserving pancreaticoduodenectomy for invasive ductal carcinoma of the pancreas.
• Significance of the serum level of soluble E-cadherin in patients with HCC.
• Single breath-hold multiarterial dynamic MRI of the liver at 3T using a 3D fat-suppressed keyhole technique.
• Situs ambiguous with gastric cancer: report of a case.
• Spectrum of MRI appearances of untreated metastases of the liver.
• Stable transfection of retinoblastoma gene promotes contact inhibition of cell growth and hepatocyte nuclear factor-1-mediated transcription in human hepatoma cells.
• The search for cancer stem cells in hepatocellular carcinoma.
• Transient vibronic structure in ultrafast fluorescence spectra of photoactive yellow protein.
• Two-step biliary external stent removal after living donor liver transplantation.